Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New developments in fluid resuscitation.

Hasan B Alam¹, Peter Rhee

¹Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, WHT 1, Boston, MA 02114, USA.

The Surgical Clinics of North America

|November 28, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Peptidyl arginine deiminase 2 (PAD2) inhibition is associated with acute and long-term benefits in a murine model of traumatic brain injury.

The journal of trauma and acute care surgery·2026

Same author

Operational Implementation of Prolonged Field Care Kits for Large-Scale Combat Operations.

Military medicine·2026

Same author

Beyond Work Relative Value Unit: Rationale for Strategic Partnership Between Health Systems and Departments of Surgery.

Journal of the American College of Surgeons·2026

Same author

Role of peptidylarginine deiminase 2 in a murine model of traumatic brain injury.

The journal of trauma and acute care surgery·2026

Same author

Prolonged partial aortic occlusion worsens neurologic outcomes without affecting brain lesion size in a swine model of traumatic brain injury and hemorrhage.

The journal of trauma and acute care surgery·2026

Same author

Valproic acid for treatment of traumatic brain injury: Study protocol for the VIBRANT prospective randomized trial.

Transfusion·2025

Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026

Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026

Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026

Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026

Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026

Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026

See all related articles

Hemorrhagic shock management is evolving. Current crystalloid fluid resuscitation may harm patients, prompting research into safer, more effective fluid alternatives for trauma care.

Area of Science:

Trauma resuscitation
Hemorrhagic shock management
Fluid therapy

Background:

Hemorrhagic shock is a primary cause of trauma mortality.
Effective hemorrhage control and resuscitation are critical for trauma patients.
Current resuscitation fluid strategies face scrutiny regarding efficacy and safety.

Purpose of the Study:

To review evolving trends in fluid resuscitation for trauma.
To examine the optimal timing, patient selection, and methods for resuscitation.
To highlight the need for novel resuscitation fluids based on toxicity data.

Main Methods:

Literature review of studies on resuscitation fluid toxicity.
Analysis of cellular toxicities associated with common resuscitation fluids.

Related Experiment Videos

Synthesis of evidence on changing resuscitation trends in trauma care.

Main Results:

Crystalloid fluid resuscitation may have detrimental effects.
Studies reveal cellular toxicities of standard resuscitation fluids.
Evidence suggests current practices may not be optimal for all trauma patients.

Conclusions:

Resuscitation fluid choices significantly impact trauma outcomes.
There is a critical need for developing and evaluating new resuscitation fluids.
Optimizing fluid resuscitation is essential for improving survival rates in hemorrhagic shock.